Constantiam Biosciences
About Constantiam Biosciences
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Phase II SBIR Grant T: - FT: Phase II SBIR Grant |
A: 2050000 MR: - FA: $2.05 million FAN: 2050000 |
D: 2024-09-04 FD: 2024-09-04 |
1 investors |
Growth Metrics
Team & Leadership
Nicholas Schafer
Co-Founder and CEO
Daniel Goldman
Co-Founder and CSO
Norman Ong
Co-Founder and Chief Commercial Officer
Nicole Persky
Director, Functional Genomics
Zainab Waseem
Marketing and Comms Strategist
Frederick Roth
Founding Scientific Advisor
Recent News
Constantiam Biosciences Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- constantiambio.com
- Industries
- Biotechnology / Genomic Medicine
- Company Size
- ~260 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro